Salvage Therapy With Low-Dose Ruxolitinib Leads to a Significant Improvement in Bronchiolitis Obliterans Syndrome in Patients With cGVHD After Allogeneic Hematopoietic Stem Cell Transplantation

Bronchiolitis obliterans syndrome (BOS) is a life-threatening pulmonary manifestation of chronic graft versus host disease (cGVHD) post-allogeneic hematopoietic stem cell transplantation (HSCT), without clear standard of care. This study included 30 patients undergoing an allogeneic HSCT for a hemat...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Yanmin, OuYang, Guifang, Shi, Jimin, Luo, Yi, Tan, Yamin, Yu, Jian, Fu, Huarui, Lai, Xiaoyu, Liu, Lizhen, Huang, He
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8273229/
https://www.ncbi.nlm.nih.gov/pubmed/34262450
http://dx.doi.org/10.3389/fphar.2021.668825

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8273229/
https://www.ncbi.nlm.nih.gov/pubmed/34262450
http://dx.doi.org/10.3389/fphar.2021.668825

Ejemplares similares